Apellis Pharmaceuticals, Inc. Quarterly Other Assets, Current in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Apellis Pharmaceuticals, Inc. quarterly Other Assets, Current history and growth rate from Q4 2016 to Q3 2024.
  • Apellis Pharmaceuticals, Inc. Other Assets, Current for the quarter ending September 30, 2024 was $11.8M, a 61.8% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $11.8M -$19.1M -61.8% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $12.4M -$14.4M -53.9% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $12.1M -$22.2M -64.7% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $22.4M -$14.3M -38.9% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $30.8M +$6.92M +28.9% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $26.8M -$1.65M -5.8% Jun 30, 2023 10-Q 2023-07-31
Q1 2023 $34.3M -$39.1M -53.2% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $36.7M -$34M -48.1% Dec 31, 2022 10-K/A 2024-02-29
Q3 2022 $23.9M +$2.95M +14% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $28.5M -$2.77M -8.86% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $73.4M +$42.2M +135% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $70.7M +$43.8M +163% Dec 31, 2021 10-K 2023-02-21
Q3 2021 $21M +$19.3M +1182% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $31.2M +$29.4M +1608% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $31.2M +$29.3M +1550% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $26.9M +$25.6M +1955% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $1.64M -$821K -33.4% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $1.83M -$1.53M -45.5% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $1.89M +$1.88M Mar 31, 2020 10-Q 2020-04-29
Q4 2019 $1.31M -$530K -28.8% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $2.46M +$2.38M +2914% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $3.36M +$3.35M Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $15.6K* -$190K Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $1.84M +$1.82M Dec 31, 2018 10-K 2020-02-27
Q3 2018 $81.5K -$3.57M -97.8% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $7.7K* Jun 30, 2018 10-Q 2018-07-31
Q1 2018 $206K Mar 31, 2018 10-Q 2018-04-30
Q4 2017 $14.8K* -$10.2K Dec 31, 2017 10-K 2019-02-26
Q3 2017 $3.65M Sep 30, 2017 10-Q 2017-12-20
Q4 2016 $25K Dec 31, 2016 10-K 2018-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.